The withdrawal of Vioxx caused Merck's's market value to sink.
Bextra was approved in 2001.
New study results showed increased risk of heart attacks and stroke in some people.
A medical director insisted that its drugs are safe.
Merck &amp; Co. removed Vioxx from use.
Grassley released the internal email exchange.
Some people die every day waiting for new treatments.
Regulators indicated plans to review COX-2 drugs.
An initial study raised similar concerns in the same kinds of patients.
Many doctors and patients liked Vioxx's's track record on gastrointestinal problems.
A study of the Vioxx safety issue became.
